Saturday, December 15, 2018

Fennec Announces Positive Results From Phase 3 SIOPEL 6 Study on PEDMARK(TM) (sodium thiosulfate)...

Study met primary endpoint (p=0.0033) Significant reduction in...

Fennec Announces Positive Results From Phase 3 SIOPEL 6 Study on PEDMARK(TM) (sodium thiosulfate)...

Study met primary endpoint (p=0.0033) Significant reduction in...

LogicBio Therapeutics to Present Preclinical Data at European Society of Gene & Cell Therapy...

· Company co-founder Professor Adi Barzel, Ph.D., to present new proof-of-concept efficacy data ...

LogicBio Therapeutics to Present Preclinical Data at European Society of Gene & Cell Therapy...

· Company co-founder Professor Adi Barzel, Ph.D., to present new proof-of-concept efficacy data ...

LogicBio Therapeutics to Present Preclinical Data at European Society of Gene & Cell Therapy...

· Company co-founder Professor Adi Barzel, Ph.D., to present new proof-of-concept efficacy data ...

Invitation to Idorsia’s nine-month results 2017 webcast and conference call

Idorsia will publish its financial results for the first nine months of 2017 on  Tuesday 24 October 2017 ...

Invitation to Idorsia’s nine-month results 2017 webcast and conference call

Idorsia will publish its financial results for the first nine months of 2017 on  Tuesday 24 October 2017 ...

Invitation to Idorsia’s nine-month results 2017 webcast and conference call

Idorsia will publish its financial results for the first nine months of 2017 on  Tuesday 24 October 2017 ...

Invitation to Idorsia’s nine-month results 2017 webcast and conference call

Idorsia will publish its financial results for the first nine months of 2017 on  Tuesday 24 October 2017 ...

No Items For Such Parameters.

No Items For Such Parameters: 'category:PR;language:en;icb:4570'.